Chinese drugmaker gives trial coronavirus vaccine to staff

Nasdaq-listed Sinovac Biotech hopes to get production license this year

CK TAN, Nikkei staff writer

SHANGHAI - Chinese drugmaker Sinovac Biotech has begun to administer a coronavirus vaccine to thousands of its staff as the race to secure an immunization for COVID-19 enters advanced clinical trials.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.